Neovasc Announces FDA Approval of COSIRA-II Clinical Trial

NEXT STORY
Boehringer Ingelheim and OSE Immunotherapeutics Present Phase 1 Results with First-in-Class SIRPα Inhibitor BI 765063 in Advanced Solid Tumors at ESMO 2021
PREV STORY
BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Summit Therapeutics Appoints Ralf Rosskamp, MD, as Chief Medical Officer

OXFORD, United Kingdom, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), ...

author_avatar
NASDAQ Market News

Atara Biotherapeutics Expands Leadership Team with the Appointment of Dr. Kanya Rajangam as Senior Vice President and Chief Medical Officer

SOUTH SAN FRANCISCO, Calif., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), ...

author_avatar
NASDAQ Market News

Vaccines Market to reach value of around US$ 48.0 Bn by 2025, Says TMR

Global Vaccines Market to Grow at a Steady Pace due to Rising Government InitiativesAlbany, ...

author_avatar
NASDAQ Market News